Overview of Tianeptine and FDA Warnings
Key Information:
- Tianeptine: Initially developed as an antidepressant in Europe, it’s unapproved in the U.S. but available as a dietary supplement, misleadingly marketed. High doses can lead to addiction, with severe side effects like seizures and potential death.
- Neptune’s Fix: The FDA advises against purchasing products from this brand due to its tianeptine content.
Expert Insights:
- Dr. Pieter Cohen (Harvard Medical School): Describes tianeptine as addictive at high doses and indicates that it has never been approved in the U.S. Its prevalence has increased alarmingly in the past decade.
Health Risks and Incidents:
- Cases Reported: Health professionals report severe reactions among users, including agitation, increased heart rates, and withdrawal symptoms akin to opioid withdrawal.
- Emergency Room Visits: Poison control centers are seeing a rise in serious cases, prompting discussions around intensive care for affected individuals.
Regulatory Challenges:
- FDA Limitations: The FDA lacks the authority to pre-approve dietary supplements before market entry. While they have issued warnings since 2018, critics argue that these measures are insufficient.
- Calls for Action: There are ongoing discussions about the role Congress can play in toughening regulations to protect consumers from dangerous supplements.
Other Supplements of Concern:
- Kratom and Phenibut: These substances also lack adequate regulation and pose similar risks. Increasing dosages of such supplements have been observed even after FDA warnings.
Conclusion:
Tianeptine’s rise in popularity reflects serious gaps in dietary supplement regulation in the U.S. Experts urge for stricter enforcement and legislative reform to ensure consumer safety against such harmful substances.
